Inventor

BILLER SCOTT A

US47 patents

⚠️ This page may combine multiple inventors who share the name “BILLER SCOTT A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BILLER SCOTT A

SQUIBB & SONS INC

Phosphorus-containing squalene synthetase inhibitors, new intermediates and method

Phosphorus-containing squalene synthetase inhibitors

Bisphosphonate squalene synthetase inhibitors and method

Phosphorus-containing HMG-COA reductase inhibitors, new intermediates and method

Phosphorus-containing HMG-CoA reductase inhibitors, new intermediates and method

Phosphorous-containing HMG-CoA reductase inhibitors, new intermediates and method

Phosphorus-containing HMG-COA reductase inhibitors

Aryl and heteroaryl(phosphinylmethyl)phosphonate squalene synthetase inhibitors and method

Aryl and heteroaryl (phosphinylmethyl)phosphonate squalene synthetase inhibitors and method

Phosphorus-containing squalene synthetase inhibitors

Isoprenoid phosphinylformic acid squalene synthetase inhibitors

Aryl-cycloalkyl[b]pyrrole derivatives

Hydroxyphosphinyl phosphonate squalene synthetase inhibitors and method

Method for lowering cholesterol employing a phosphonomethylphosphinate squalene synthetase inhibitor

Phosphorus-containing squalene synthetase inhibitors and method

1,2,3,4-tetrahydro-8-quinolinol derivatives and anti-allergic use thereof

Method for preparing isoprenoid cyclopropane 1,1-dicarboxylates and derivatives thereof and novel intermediates

Method for blocking neoplastic transformation of cells induced by ras oncogenes

Process of making isoprenoid phosphinylformic acid squalene synthetase inhibitors

Method for preparing isoprenoid cyclopropane 1,1-dicarboxylates and derivatives thereof and novel intermediates

Isoprenoid phosphinylformic acid squalene synthetase inhibitors and method

Method for preparing isoprenoid cyclopropane 1,1-dicarboxylates

BRISTOL MYERS SQUIBB CO

Inhibitors of microsomal triglyceride transfer protein and method

Inhibitors of microsomal triglyceride transfer protein and method

Inhibitors of microsomal triglyceride transfer protein and method

Protein farnesyl transferase inhibitors

Inhibitors of microsomal triglyceride transfer protein and method

Nucleic acids encoding microsomal trigyceride transfer protein

α-phosphonosulfinic squalene synthetase inhibitors

α-phosphonocarboxylate squalene synthetase inhibitors

Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method

Inhibitors of microsomal triglyceride transfer protein and method

Inhibitors of microsomal triglyceride transfer protein and method

Microsomal triglyceride transfer protein

Method for treating diabetes employing an aP2 inhibitor and combination

Method for treating atherosclerosis employing an aP2 inhibitor and combination

Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia

Method for preparing compounds employing solid phase synthesis and novel linker-resin

α-phosphonosulfonate squalene synthetase inhibitors and method

Method for treating a fungal infection

Inhibitors of microsomal triglyceride transfer protein and method

Aminobiphenyl-4-ol anti-atherosclerotic compounds and method

(unassigned)

Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method

α-phosphonosulfonate squalene synthetase inhibitors

Methods of preparing α-phosphonosulfinate squalene synthetase inhibitors

Method for preventing or treating hypertriglyceridemia

BRISTOL MEYERS SQUIBB CO

Inhibitors of farnesyl protein transferase